ERICA NYMAN: Open Payments
NPI 1316071301 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,716 in 141 payments from 24 companies in 2025. Trend: 2023 $2,903 · 2024 $3,217 · 2025 $2,716
Food & beverage: $2,541Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $492 |
| ABBVIE INC. | 20 | $263 |
| AstraZeneca Pharmaceuticals LP | 11 | $209 |
| Lilly USA, LLC | 9 | $200 |
| Amgen Inc. | 2 | $187 |
| Otsuka America Pharmaceutical, Inc. | 13 | $178 |
| PFIZER INC. | 11 | $176 |
| Neurocrine BioSciences, Inc. | 7 | $169 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $156 |
| Lundbeck LLC | 5 | $147 |
Products named: REXULTI, Wegovy, PROLIA, MOUNJARO, INGREZZA, AIRSUPRA, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
